These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30820705)

  • 21. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
    Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
    Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.
    Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
    Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
    Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY
    Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
    Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
    Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study.
    Kollar M; Krajciova J; Prefertusova L; Sticova E; Maluskova J; Vackova Z; Martinek J
    United European Gastroenterol J; 2020 May; 8(4):436-443. PubMed ID: 32213027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
    Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
    World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Gacuta E; Szmitkowski M; Chrostek L; Ławicki S
    Tumour Biol; 2018 Jul; 40(7):1010428318790363. PubMed ID: 30052166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
    Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
    Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.